Wouter Koudstaal, Ph.D., brings over 15 years of R&D experience in academic, biotech, and pharma settings having focused on the discovery and early (preclinical) development of vaccines and therapeutics in the fields of infectious diseases and neuroscience at Crucell, a Dutch biotech company, and Janssen. Moreover, Koudstaal conducted part of his research at the Beth Israel Deaconess Medical Center (BIDMC) of Harvard Medical School in Boston and at Imperial College, London. At Janssen, he has led a team responsible for design and critical review of research programs and overall research strategy, as well as for the scientific output in the form of publications, strategic presentations and pitches. Koudstaal is an independent consultant offering expertise on output-oriented design and management of (public-private collaborative) research programs. Wouter holds an MSc degree in Biology from the University of Utrecht (Netherlands) and a PhD in Medicine from the University of Amsterdam (Netherlands).
Wouter Koudstaal is part of the scientific team of the long-term partnership between the Harvard T.H. Chan School of Public Health and HVP, the Human Immunomics Initiative.